Physician profile
Janelle Evans
NPI 1912058041
$4,609.26
in general payments reported to CMS, 2019-2025
15 companies · $693 in 2025
The $693 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,370 · 2020: $45.62 · 2021: $1,500 · 2022: $373 · 2023: $330 · 2024: $299 · 2025: $693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,321.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,292.47 | 2021-2024 | Axonics, Bulkamid |
| Stryker Corporation | $700.00 | 2019 | |
| Medtronic USA, INC. | $380.27 | 2019 | |
| Boston Scientific Corporation | $292.83 | 2021-2025 | Axonics |
| Medtronic, INC. | $185.26 | 2022-2025 | Interstim |
| C. R. Bard, INC. & Subsidiaries | $179.26 | 2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Coloplast Corp | $154.86 | 2019-2025 | |
| Smith+Nephew, INC. | $138.47 | 2019 | |
| Sumitomo Pharma America, INC. | $121.51 | 2024-2025 | Gemtesa |
| Contura, INC. | $45.62 | 2020 | |
| Tolmar, INC. | $31.03 | 2025 | Jatenzo, Eligard |
| 180 Medical, INC. | $27.44 | 2025 | |
| Urogen Pharma, INC. | $26.44 | 2025 | |
| Calyxo, INC. | $22.80 | 2025 | Cvac Aspiration System |
| Amag Pharmaceuticals, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janelle Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.